Patents for A61P 33 - Antiparasitic agents (21,787)
05/1993
05/13/1993WO1993008822A1 Treatment of protozoal infection with bacitracin
05/13/1993WO1993008816A1 Pharmaceutical lysine-containing polypeptide compositions and methods of use thereof
05/13/1993WO1993008815A1 Pharmaceutical dipeptide compositions and methods of use thereof
05/13/1993CA2122024A1 Pharmaceutical lysine-containing polypeptide compositions and methods of use thereof
05/04/1993US5208222 Anthelemetic
04/1993
04/29/1993WO1993008195A1 Cyclic peroxyacetal compounds
04/29/1993WO1993007856A1 LOW pH AQUEOUS COSMETIC GEL CONTAINING NON-IONIC POLYACRYLAMIDE DERIVATIVES
04/28/1993EP0538437A1 Immunostimulating and immunopotentiating reconstituted influenza virosomes and vaccines containing them
04/27/1993US5206008 Using androstene(diol or triol)
04/27/1993CA1316915C Macrolide antibiotics and their preparation
04/21/1993EP0538193A2 Condensed cycloaliphatir-amidino-hydrazon salts as S-adenosylmethionin decarboxylase inhibitors
04/21/1993EP0537996A1 Avermectin compounds with a 6,5-spiroketal ring system and a 23-acyl substituent
04/21/1993EP0537947A1 Naphthoquinone derivatives for the treatment of parasitic infections
04/21/1993EP0526570A4 Composition and treatment with biologically active peptides and anti-parasitic agents or anti-fungal agents
04/15/1993WO1993007156A1 Naphthoquinone derivatives for the treatment of parasitic infections
04/15/1993WO1993007125A1 2-substituted quinolines for treating leishmanioses
04/15/1993CA2117179A1 Heterocyclic compounds
04/14/1993EP0536335A1 Compositions and methods for the prevention and diagnosis of lyme disease
04/07/1993EP0535734A1 Long acting injectable formulations containing hydrogenated castor oil
04/06/1993CA1315678C Alpha-tocopherol based vesicles
03/1993
03/31/1993EP0534445A1 Process for the preparation of a medicament for oral or topical administration in the treatment of leishmaniasis
03/31/1993CA2079255A1 Long acting injectable formulations containing hydrogenated castor oil
03/30/1993CA1315287C Substituted bis-(4-aminophenyl)-sulfones, their preparation and their use as pharmaceutical compositions
03/24/1993EP0533281A1 The use of ranitidine bismuth citrate and one or more heliocobacte pylon-inhibiting antibiotics with manufacture of a medicament for treating gastrointestinal disorders
03/21/1993CA2078579A1 Medicaments for treating gastrointestinal disorders
03/10/1993EP0530901A1 13-beta-O-methoxymethyl-22,23-dihydro avermectin B1A/B1B aglycone
03/09/1993US5192671 Fermentation with Saccharopolyspora
03/05/1993CA2077131A1 13beta-o-methoxymethyl-22,23-dihydro avermectin b1a-b1b aglycone as a superior antiparasitic agent
03/04/1993WO1993003738A1 Method for treating vascular obstructions caused by abnormal cells
03/04/1993CA2115361A1 Method for treating vascular obstructions caused by abnormal cells
02/1993
02/24/1993EP0527771A1 Polypeptides useful in diagnosis of and treatment against mycoplasma infections in animals
02/23/1993CA1313816C Anthelmintic active compound combinations
02/18/1993WO1993002676A1 The use of dioxapyrrolomycin as an antiparasitic agent and compositions useful therefor
02/18/1993CA2112704A1 The use of dioxapyrrolomycin as an antiparasitic agent and compositions useful therefor
02/10/1993EP0526570A1 Composition and treatment with biologically active peptides and anti-parasitic agents or anti-fungal agents
02/10/1993CN1068735A Stable compositions for parenteral adiministration and thier use
02/04/1993WO1993002059A1 Benzimidazole anthelmintic agents
02/04/1993WO1993002058A1 Benzimidazole anthelmintics
02/03/1993EP0525307A1 Stable compositions for parenteral administration and their use
02/03/1993CN1068569A Dithiane
02/02/1993CA1313329C Nicarbazin feed premix
01/1993
01/27/1993EP0524686A1 A process for the 14a-hydroxylation of avermectin compounds
01/26/1993CA1313155C Antibiotic compounds and their preparation
01/24/1993CA2074328A1 Process for the 14a-hydroxylation of avermectin compounds
01/21/1993WO1993001276A1 Continuous cell line and vaccine against avian coccidia
01/21/1993WO1993001202A1 Treatment of chemotherapeutic agent and antiviral agent toxicity with acylated pyrimidine nucleosides
01/20/1993EP0523529A2 Anticoccidial compositions
01/20/1993EP0523523A1 Anticoccidial compositions
01/20/1993EP0523512A1 8-vinyl- and 8-ethinyl-quinolone carboxylic acids
01/20/1993EP0523493A1 Dithianes
01/20/1993CA2073993A1 8-vinyl- and 8-ethinyl-quinolone-carboxylic acids
01/19/1993US5180741 Pyrethrinoid esters carrying an indanyl nucleus and their use as pesticides
01/19/1993US5180714 Adenosine compounds for the treatment of diseases caused by parasitic protozoa
01/19/1993CA2074062A1 Dithiane
01/13/1993EP0522482A2 Coccidiosis vaccines
01/13/1993CA2073588A1 Coccidiosis vaccines
01/12/1993US5179096 Therapeutic application of flouroquinolone derivatives
01/12/1993US5179078 Method of suppressing tumor formation in vivo
01/07/1993WO1993000084A1 Methods and compositions for treating malaria and other diseases
01/07/1993WO1992017173A3 Use of riboflavin for treating hiv-related diseases, herpes, retinitis pigmentosa and malaria
01/07/1993EP0521781A1 Pyrethinoide esters of 2,3-dihydro 4-methyl 2-oxo 3-(2-propynyl) thiazole-2-methanol, process for their preparation and their use as pesticides
01/07/1993EP0521463A2 Substituted cyclic cycloalkyltriols, process, intermediates for their preparation and their use as antiviral and antiparasitic agents
01/05/1993US5177063 Avermectin compounds with a 6,5-spiroketal ring system
01/05/1993CA2073111A1 Cycloalkyltriols containing cyclic substituents, processes and intermediate products for their preparation and their use as antiviral and antiparasitic agents
12/1992
12/31/1992WO1993000082A1 Pharmaceutical compositions comprising hydroxamate derivatives for iron removal
12/31/1992CA2090426A1 Pharmaceutical compositions comprising hydroxamate derivatives for iron removal
12/30/1992EP0520865A1 Use of acid derivatives for the preparation of a pediculicidal medicament
12/30/1992EP0520557A1 A process for the glycosylation of avermectin compounds
12/30/1992EP0520275A2 2-(3-Substituted phenylhydrazino)-2-thiazoline and 2-(3-substituted phenylazo)-2-thiazoline, their preparation and their use against ectoparasites
12/30/1992EP0520274A2 2-(-4-substituted-phenylhydrazino)-2-thiazoline and 2-(-4-substituted phenylazo)-2-thiazoline, their preparation and their use against ectoparasites
12/30/1992EP0412982B1 Paromomycin or derivatives thereof for parenteral treatment of human parasitic diseases
12/28/1992CA2072227A1 2-(3-substituted phenylhydrazino)-2-thiazolines and 2-(3-substituted phenylazo)-2-thiazolines, their preparation, and their use for combating ectoparasites
12/28/1992CA2072217A1 2-(4-substituted phenylhydrazino)-2-thiazolines and 2-(4-substituted phenylazo)-2-thiazolines, their preparation, and their use for combating ectoparasites
12/27/1992CA2071574A1 Process for the glycosylation of avermectin compounds
12/23/1992EP0519731A1 4a-Substituted avermectin derivatives
12/23/1992EP0519547A2 Coccidiosis poultry vaccine
12/23/1992EP0519290A1 Use of 6(7)-amino-substituted-5,8-quinolinediones to combat endoparasites, new 6(7)-aminosubstituted 5,8-quinolinediones and processes for their preparation
12/22/1992CA2071566A1 6(7)-amino-substituted quinoline-5,8-quinones for combating endoparasites, new 6(7)-amino-substituted quinoline-5,8-quinones and processes for their preparation
12/21/1992CA2071803A1 4a-substituted avermectin derivatives
12/19/1992CA2071395A1 Coccidiosis poultry vaccine
12/15/1992US5171742 Parasiticides, insecticides
12/15/1992US5171741 Treating undesired biological target to destroy infected cells or viruses
12/08/1992US5169839 Pesticides for animals and plants
12/08/1992CA1311242C Pesticidal method using n-phenylpyrazoles
12/02/1992EP0516396A1 Eimeria acervulina dna probes
12/02/1992EP0516395A2 Eimeria necatrix dna probes
12/02/1992EP0516391A2 Eimeria brunetti dna probes
12/02/1992EP0516386A1 Eimeria mitis DNA probes
12/02/1992EP0516385A1 Eimeria tenella DNA probes
12/02/1992EP0516384A1 Eimeria praecox DNA probes
12/02/1992EP0516383A2 Eimeria maxima dna probes
12/02/1992CN1019302B Polycyclic ether antibioties
11/1992
11/30/1992CA2069765A1 Eimeria tenella dna probes
11/30/1992CA2069588A1 Eimeria maxima dna probes
11/30/1992CA2069583A1 Eimeria acervulina dna probes
11/30/1992CA2069573A1 Eimeria necatrix dna probes
11/30/1992CA2069563A1 Eimeria mitis dna probes
11/30/1992CA2069535A1 Eimeria praecox dna probes
11/30/1992CA2069533A1 Eimeria brunetti dna probes
11/26/1992WO1992020642A1 Bis mono-and bicyclic aryl and heteroaryl compounds which inhibit egf and/or pdgf receptor tyrosine kinase